Venture
AEON Biopharma, Inc.
Latest Form D 2022-08-11- CIK 1622667
- State CA
- Pharmaceuticals
- 6 Form D offerings since 2015-01-22
- Total sold
- $197M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2015-01-22
- Latest round
- $30M
- 2022-08-11 · 021-455635
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2022-08-11 · $30M
- 2015-01-22$27M021-232710
- 2015-11-20$80.1M021-251658
- 2016-08-10$5.5M021-268648
- 2020-08-31$30M021-374494
- 2022-08-11$24.5M021-455629
- 2022-08-11$30M021-455635
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($80.1M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-455635 | First filed2022-08-11 | Latest2022-08-11 | Sought$30M | Sold$30M | Investors1 | Exemptions506(b) |
| 021-455629 | First filed2022-08-11 | Latest2022-08-11 | Sought$25M | Sold$24.5M | Investors1 | Exemptions506(b) |
| 021-374494 | First filed2020-08-31 | Latest2021-05-13 | Sought$30M | Sold$30M | Investors1 | Exemptions506(b) |
| 021-268648 | First filed2016-08-10 | Latest2016-08-10 | Sought$55M | Sold$5.5M | Investors5 | Exemptions506(b) |
| 021-251658 | First filed2015-11-20 | Latest2015-11-20 | Sought$150M | Sold$80.1M | Investors28 | Exemptions506(b) |
| 021-232710 | First filed2015-01-22 | Latest2015-01-22 | Sought$40.5M | Sold$27M | Investors5 | Exemptions506(b) |
Who backs AEON Biopharma, Inc. — 3 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2022-08-11
| Name | Relationship |
|---|---|
| Simone Blank | RelationshipDirector |
| Jost Fischer | RelationshipDirector |
| Robert Grant | RelationshipDirector |
| Vikram Malik | RelationshipDirector |
| Darren O'Brien | RelationshipDirector |
| Richard Taketa | RelationshipDirector |
| Marc Forth | RelationshipExecutive Officer |
| Chris Carr | RelationshipExecutive Officer |
| Alex Wilson | RelationshipExecutive Officer |
| Chad Oh | RelationshipExecutive Officer |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Piper Jaffray & Co. | CRD665 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Pharmaceuticals
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2015-01-22
- Latest filing
- 2022-08-11
Who backs AEON Biopharma, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗